- Home
- OFLX vs ATXS Comparison
OFLX vs ATXS Comparison
Compare OFLX & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- ATXS
- Stock Information
- Founded
- OFLX 1975
- ATXS 2008
- Country
- OFLX United States
- ATXS United States
- Employees
- OFLX N/A
- ATXS N/A
- Industry
- OFLX Industrial Specialties
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- ATXS Health Care
- Exchange
- OFLX Nasdaq
- ATXS Nasdaq
- Market Cap
- OFLX 366.4M
- ATXS 424.4M
- IPO Year
- OFLX 2005
- ATXS 2015
- Fundamental
- Price
- OFLX $34.31
- ATXS $7.37
- Analyst Decision
- OFLX
- ATXS Buy
- Analyst Count
- OFLX 0
- ATXS 6
- Target Price
- OFLX N/A
- ATXS $32.00
- AVG Volume (30 Days)
- OFLX 18.1K
- ATXS 315.6K
- Earning Date
- OFLX 10-29-2025
- ATXS 11-12-2025
- Dividend Yield
- OFLX 3.91%
- ATXS N/A
- EPS Growth
- OFLX N/A
- ATXS N/A
- EPS
- OFLX 1.69
- ATXS N/A
- Revenue
- OFLX $100,700,000.00
- ATXS N/A
- Revenue This Year
- OFLX N/A
- ATXS N/A
- Revenue Next Year
- OFLX N/A
- ATXS N/A
- P/E Ratio
- OFLX $20.00
- ATXS N/A
- Revenue Growth
- OFLX N/A
- ATXS N/A
- 52 Week Low
- OFLX $28.12
- ATXS $3.56
- 52 Week High
- OFLX $57.81
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- OFLX 50.57
- ATXS 57.31
- Support Level
- OFLX $33.32
- ATXS $7.12
- Resistance Level
- OFLX $35.26
- ATXS $7.94
- Average True Range (ATR)
- OFLX 1.20
- ATXS 0.48
- MACD
- OFLX -0.14
- ATXS 0.06
- Stochastic Oscillator
- OFLX 31.73
- ATXS 69.38
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.